Review Article | Published:

Haematopoietic stem cell activity and interactions with the niche

Nature Reviews Molecular Cell Biology (2019) | Download Citation


The haematopoietic stem cell (HSC) microenvironment in the bone marrow, termed the niche, ensures haematopoietic homeostasis by controlling the proliferation, self-renewal, differentiation and migration of HSCs and progenitor cells at steady state and in response to emergencies and injury. Improved methods for HSC isolation, driven by advances in single-cell and molecular technologies, have led to a better understanding of their behaviour, heterogeneity and lineage fate and of the niche cells and signals that regulate their function. Niche regulatory signals can be in the form of cell-bound or secreted factors and other local physical cues. A combination of technological advances in bone marrow imaging and genetic manipulation of crucial regulatory factors has enabled the identification of several candidate cell types regulating the niche, including both non-haematopoietic (for example, perivascular mesenchymal stem and endothelial cells) and HSC-derived (for example, megakaryocytes, macrophages and regulatory T cells), with better topographical understanding of HSC localization in the bone marrow. Here, we review advances in our understanding of HSC regulation by niches during homeostasis, ageing and cancer, and we discuss their implications for the development of therapies to rejuvenate aged HSCs or niches or to disrupt self-reinforcing malignant niches.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Additional information

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


  1. 1.

    Jagannathan-Bogdan, M. & Zon, L. I. Hematopoiesis. Development 140, 2463–2467 (2013).

  2. 2.

    Kaushansky, K. Lineage-specific hematopoietic growth factors. N. Engl. J. Med. 354, 2034–2045 (2006).

  3. 3.

    Laurenti, E. & Gottgens, B. From haematopoietic stem cells to complex differentiation landscapes. Nature 553, 418–426 (2018).

  4. 4.

    Jacobson, L. O., Simmons, E. L., Marks, E. K. & Eldredge, J. H. Recovery from radiation injury. Science 113, 510–511 (1951).

  5. 5.

    Till, J. E. & McCulloch, C. E. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14, 213–222 (1961).

  6. 6.

    Wilson, A. et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 135, 1118–1129 (2008).

  7. 7.

    Essers, M. A. et al. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 458, 904–908 (2009).

  8. 8.

    Baldridge, M. T., King, K. Y., Boles, N. C., Weksberg, D. C. & Goodell, M. A. Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature 465, 793–797 (2010).

  9. 9.

    Walter, D. et al. Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells. Nature 520, 549–552 (2015).

  10. 10.

    Cheshier, S. H., Morrison, S. J., Liao, X. & Weissman, I. L. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc. Natl Acad. Sci. USA 96, 3120–3125 (1999).

  11. 11.

    Cheng, T. et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287, 1804–1808 (2000).

  12. 12.

    Arai, F. et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118, 149–161 (2004).

  13. 13.

    Passegue, E., Wagers, A. J., Giuriato, S., Anderson, W. C. & Weissman, I. L. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J. Exp. Med. 202, 1599–1611 (2005).

  14. 14.

    Sun, J. et al. Clonal dynamics of native haematopoiesis. Nature 514, 322–327 (2014).

  15. 15.

    Busch, K. et al. Fundamental properties of unperturbed haematopoiesis from stem cells in vivo. Nature 518, 542–546 (2015).

  16. 16.

    Sawai, C. M. et al. Hematopoietic stem cells are the major source of multilineage hematopoiesis in adult animals. Immunity 45, 597–609 (2016).

  17. 17.

    Haas, S., Trumpp, A. & Milsom, M. D. Causes and consequences of hematopoietic stem cell heterogeneity. Cell Stem Cell 22, 627–638 (2018).

  18. 18.

    Notta, F. et al. Distinct routes of lineage development reshape the human blood hierarchy across ontogeny. Science 351, aab2116 (2016).

  19. 19.

    Yamamoto, R. et al. Clonal analysis unveils self-renewing lineage-restricted progenitors generated directly from hematopoietic stem cells. Cell 154, 1112–1126 (2013).

  20. 20.

    Schofield, R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 4, 7–25 (1978).

  21. 21.

    Asada, N., Takeishi, S. & Frenette, P. S. Complexity of bone marrow hematopoietic stem cell niche. Int. J. Hematol. 106, 45–54 (2017).

  22. 22.

    Muller-Sieburg, C. E., Cho, R. H., Thoman, M., Adkins, B. & Sieburg, H. B. Deterministic regulation of hematopoietic stem cell self-renewal and differentiation. Blood 100, 1302–1309 (2002).

  23. 23.

    Dykstra, B. et al. Long-term propagation of distinct hematopoietic differentiation programs in vivo. Cell Stem Cell 1, 218–229 (2007).

  24. 24.

    Foudi, A. et al. Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells. Nat. Biotechnol. 27, 84–90 (2009).

  25. 25.

    Benveniste, P. et al. Intermediate-term hematopoietic stem cells with extended but time-limited reconstitution potential. Cell Stem Cell 6, 48–58 (2010).

  26. 26.

    Challen, G. A., Boles, N. C., Chambers, S. M. & Goodell, M. A. Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1. Cell Stem Cell 6, 265–278 (2010).

  27. 27.

    Morita, Y., Ema, H. & Nakauchi, H. Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment. J. Exp. Med. 207, 1173–1182 (2010).

  28. 28.

    Benz, C. et al. Hematopoietic stem cell subtypes expand differentially during development and display distinct lymphopoietic programs. Cell Stem Cell 10, 273–283 (2012).

  29. 29.

    Sanjuan-Pla, A. et al. Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy. Nature 502, 232–236 (2013).

  30. 30.

    Kunisaki, Y. et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 502, 637–643 (2013). This study uses whole-mount 3D-imaging and computer randomization models to show that a subset of quiescent HSCs associate with NG2 + periarteriolar niche cells, whereas the most proliferative HSCs distribute away from arterioles.

  31. 31.

    Itkin, T. et al. Distinct bone marrow blood vessels differentially regulate haematopoiesis. Nature 532, 323–328 (2016). This study suggests that the differential permeability of blood vessels to plasma affects the levels of ROS in nearby HSCs such that HSCs associated with the less-permeable arterioles contain low ROS levels and thus are quiescent, whereas HSCs associated with the more-permeable sinusoids have increased ROS levels, leading to their differentiation and migration into the circulation.

  32. 32.

    Pinho, S. et al. Lineage-biased hematopoietic stem cells are regulated by distinct niches. Dev. Cell 44, 634–641 (2018). This study uses Vwf –GFP mice and 3D whole-mount confocal imaging to demonstrate the existence of spatially and functionally distinct bone marrow niches for HSC subsets that have distinct developmental potential.

  33. 33.

    Notta, F. et al. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 333, 218–221 (2011).

  34. 34.

    Osawa, M., Hanada, K., Hamada, H. & Nakauchi, H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273, 242–245 (1996).

  35. 35.

    Birbrair, A. & Frenette, P. S. Niche heterogeneity in the bone marrow. Ann. NY Acad. Sci. 1370, 82–96 (2016).

  36. 36.

    Kricun, M. E. Red-yellow marrow conversion: its effect on the location of some solitary bone lesions. Skeletal Radiol. 14, 10–19 (1985).

  37. 37.

    Kiel, M. J., Iwashita, T., Yilmaz, O. H. & Morrison, S. J. Spatial differences in hematopoiesis but not in stem cells indicate a lack of regional patterning in definitive hematopoietic stem cells. Dev. Biol. 283, 29–39 (2005).

  38. 38.

    Lo Celso, C. et al. Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature 457, 92–96 (2009).

  39. 39.

    Xie, Y. et al. Detection of functional haematopoietic stem cell niche using real-time imaging. Nature 457, 97–101 (2009).

  40. 40.

    Nilsson, S. K., Johnston, H. M. & Coverdale, J. A. Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 97, 2293–2299 (2001).

  41. 41.

    Ellis, S. L. et al. The relationship between bone, hemopoietic stem cells, and vasculature. Blood 118, 1516–1524 (2011).

  42. 42.

    Guezguez, B. et al. Regional localization within the bone marrow influences the functional capacity of human HSCs. Cell Stem Cell 13, 175–189 (2013).

  43. 43.

    Nombela-Arrieta, C. et al. Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment. Nat. Cell Biol. 15, 533–543 (2013).

  44. 44.

    Suzuki, N. et al. Combinatorial Gata2 and Sca1 expression defines hematopoietic stem cells in the bone marrow niche. Proc. Natl Acad. Sci. USA 103, 2202–2207 (2006).

  45. 45.

    Haylock, D. N. et al. Hemopoietic stem cells with higher hemopoietic potential reside at the bone marrow endosteum. Stem Cells 25, 1062–1069 (2007).

  46. 46.

    Grassinger, J., Haylock, D. N., Williams, B., Olsen, G. H. & Nilsson, S. K. Phenotypically identical hemopoietic stem cells isolated from different regions of bone marrow have different biologic potential. Blood 116, 3185–3196 (2010).

  47. 47.

    Acar, M. et al. Deep imaging of bone marrow shows non-dividing stem cells are mainly perisinusoidal. Nature 526, 126–130 (2015). This study uses optical clearing and deep-BM confocal imaging to demonstrate that α-catulin-positive KIT + HSCs are uniformly distributed in the marrow space.

  48. 48.

    Chanavaz, M. Anatomy and histophysiology of the periosteum: quantification of the periosteal blood supply to the adjacent bone with 85Sr and gamma spectrometry. J. Oral Implantol. 21, 214–219 (1995).

  49. 49.

    Maryanovich, M., Takeishi, S. & Frenette, P. S. Neural regulation of bone and bone marrow. Cold Spring Harb. Perspect. Med. 8, a031344 (2018).

  50. 50.

    Bellinger, D. L., Lorton, D., Felten, S. Y. & Felten, D. L. Innervation of lymphoid organs and implications in development, aging, and autoimmunity. Int. J. Immunopharmacol. 14, 329–344 (1992).

  51. 51.

    Mach, D. B. et al. Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience 113, 155–166 (2002).

  52. 52.

    Bajayo, A. et al. Skeletal parasympathetic innervation communicates central IL-1 signals regulating bone mass accrual. Proc. Natl Acad. Sci. USA 109, 15455–15460 (2012).

  53. 53.

    Yamazaki, K. & Allen, T. D. Ultrastructural morphometric study of efferent nerve terminals on murine bone marrow stromal cells, and the recognition of a novel anatomical unit: the “neuro-reticular complex”. Am. J. Anat. 187, 261–276 (1990).

  54. 54.

    Mendez-Ferrer, S. et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829–834 (2010). This study identifies perivascular Nes –GFP + MSCs in the mouse BM as crucial HSC niche regulators.

  55. 55.

    Watson, E. C. & Adams, R. H. Biology of bone: the vasculature of the skeletal system. Cold Spring Harb. Perspect. Med. 8, a031559 (2018).

  56. 56.

    Mysorekar, V. R. Diaphysial nutrient foramina in human long bones. J. Anat. 101, 813–822 (1967).

  57. 57.

    Kusumbe, A. P., Ramasamy, S. K. & Adams, R. H. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature 507, 323–328 (2014).

  58. 58.

    Kusumbe, A. P. et al. Age-dependent modulation of vascular niches for haematopoietic stem cells. Nature 532, 380–384 (2016). This study shows that the BM vasculature and associated osteoprogenitors change with age and that activation of endothelial Notch signalling can rescue these alterations.

  59. 59.

    Langen, U. H. et al. Cell-matrix signals specify bone endothelial cells during developmental osteogenesis. Nat. Cell Biol. 19, 189–201 (2017).

  60. 60.

    Ramasamy, S. K. et al. Blood flow controls bone vascular function and osteogenesis. Nat. Commun. 7, 13601 (2016).

  61. 61.

    Trueta, J. & Morgan, J. D. The vascular contribution to osteogenesis. I. Studies by the injection method. J. Bone Joint Surg. Br. 42B, 97–109 (1960).

  62. 62.

    Ramasamy, S. K. et al. Regulation of hematopoiesis and osteogenesis by blood vessel-derived signals. Annu. Rev. Cell Dev. Biol. 32, 649–675 (2016).

  63. 63.

    Gao, X., Xu, C., Asada, N. & Frenette, P. S. The hematopoietic stem cell niche: from embryo to adult. Development 145, dev139691 (2018).

  64. 64.

    Avecilla, S. T. et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat. Med. 10, 64–71 (2004).

  65. 65.

    Kiel, M. J., Yilmaz, O. H., Iwashita, T., Terhorst, C. & Morrison, S. J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121, 1109–1121 (2005). This study shows that markers of the SLAM family can be used to enrich for HSCs, enabling HSCs to be identified and localized by imaging of tissue sections, which suggests the existence of a perivascular niche.

  66. 66.

    Wei, Q. & Frenette, P. S. Niches for hematopoietic stem cells and their progeny. Immunity 48, 632–648 (2018).

  67. 67.

    Lord, B. I., Testa, N. G. & Hendry, J. H. The relative spatial distributions of CFUs and CFUc in the normal mouse femur. Blood 46, 65–72 (1975).

  68. 68.

    Gong, J. K. Endosteal marrow: a rich source of hematopoietic stem cells. Science 199, 1443–1445 (1978).

  69. 69.

    Taichman, R. S., Reilly, M. J. & Emerson, S. G. Human osteoblasts support human hematopoietic progenitor cells in vitro bone marrow cultures. Blood 87, 518–524 (1996).

  70. 70.

    Calvi, L. M. et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425, 841–846 (2003).

  71. 71.

    Zhang, J. et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425, 836–841 (2003).

  72. 72.

    Visnjic, D. et al. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 103, 3258–3264 (2004).

  73. 73.

    Bromberg, O. et al. Osteoblastic N-cadherin is not required for microenvironmental support and regulation of hematopoietic stem and progenitor cells. Blood 120, 303–313 (2012).

  74. 74.

    Greenbaum, A. M., Revollo, L. D., Woloszynek, J. R., Civitelli, R. & Link, D. C. N-Cadherin in osteolineage cells is not required for maintenance of hematopoietic stem cells. Blood 120, 295–302 (2012).

  75. 75.

    Kiel, M. J., Acar, M., Radice, G. L. & Morrison, S. J. Hematopoietic stem cells do not depend on N-cadherin to regulate their maintenance. Cell Stem Cell 4, 170–179 (2009).

  76. 76.

    Nagasawa, T. et al. Defects of B cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382, 635–638 (1996).

  77. 77.

    Petit, I. et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3, 687–694 (2002).

  78. 78.

    Ara, T. et al. Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny. Immunity 19, 257–267 (2003).

  79. 79.

    Sugiyama, T., Kohara, H., Noda, M. & Nagasawa, T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25, 977–988 (2006). This study shows that reticular perivascular and periendosteal cells in the mouse BM are a major source of CXCL12, a factor that is required for HSC maintenance.

  80. 80.

    Barker, J. E. Sl/Sld hematopoietic progenitors are deficient in situ. Exp. Hematol. 22, 174–177 (1994).

  81. 81.

    Ogawa, M. et al. Expression and function of c-kit in hemopoietic progenitor cells. J. Exp. Med. 174, 63–71 (1991).

  82. 82.

    Ikuta, K. & Weissman, I. L. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc. Natl Acad. Sci. USA 89, 1502–1506 (1992).

  83. 83.

    Zou, Y. R., Kottmann, A. H., Kuroda, M., Taniuchi, I. & Littman, D. R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393, 595–599 (1998).

  84. 84.

    Ding, L., Saunders, T. L., Enikolopov, G. & Morrison, S. J. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481, 457–462 (2012). This study uses genetic analyses to suggest that endothelial cells and LEPR + stromal cells are the main HSC niche candidates that synthesize SCF in the mouse BM.

  85. 85.

    Ding, L. & Morrison, S. J. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 495, 231–235 (2013). This study uses genetic analyses to suggest that endothelial cells and LEPR + stromal cells are the main HSC niche candidates that synthesize CXCL12 in the mouse BM, whereas lymphoid progenitors depend on CXCL12 synthesized by osteoblasts.

  86. 86.

    Greenbaum, A. et al. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature 495, 227–230 (2013). This study uses genetic analyses to suggest that endothelial and PRX1 + stromal cells are a major HSC niche candidate that synthesizes CXCL12 in the mouse BM, whereas lymphoid progenitors depend on CXCL12 synthesized by osteolineage progenitors.

  87. 87.

    Stier, S. et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J. Exp. Med. 201, 1781–1791 (2005).

  88. 88.

    Nilsson, S. K. et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 106, 1232–1239 (2005).

  89. 89.

    Qian, H. et al. Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell 1, 671–684 (2007).

  90. 90.

    Yoshihara, H. et al. Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell 1, 685–697 (2007).

  91. 91.

    Zhou, B. O., Ding, L. & Morrison, S. J. Hematopoietic stem and progenitor cells regulate the regeneration of their niche by secreting angiopoietin-1. eLife 4, e05521 (2015).

  92. 92.

    Decker, M., Leslie, J., Liu, Q. & Ding, L. Hepatic thrombopoietin is required for bone marrow hematopoietic stem cell maintenance. Science 360, 106–110 (2018).

  93. 93.

    Zhu, J. et al. Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells. Blood 109, 3706–3712 (2007).

  94. 94.

    Yu, V. W. et al. Specific bone cells produce DLL4 to generate thymus-seeding progenitors from bone marrow. J. Exp. Med. 212, 759–774 (2015).

  95. 95.

    Sacchetti, B. et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131, 324–336 (2007). This study provides evidence for a human BM MSPC population that is capable of generating heterotopic marrow that contains host HSCs after subcutaneous transplantation.

  96. 96.

    Frenette, P. S., Pinho, S., Lucas, D. & Scheiermann, C. Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. Annu. Rev. Immunol. 31, 285–316 (2013).

  97. 97.

    Chan, C. K. et al. Endochondral ossification is required for haematopoietic stem-cell niche formation. Nature 457, 490–494 (2009).

  98. 98.

    Katayama, Y. et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124, 407–421 (2006). This study identifies a role for the SNS in regulating HSC mobilization from the BM in response to G-CSF.

  99. 99.

    Mendez-Ferrer, S., Lucas, D., Battista, M. & Frenette, P. S. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 452, 442–447 (2008).

  100. 100.

    Lucas, D., Battista, M., Shi, P. A., Isola, L. & Frenette, P. S. Mobilized hematopoietic stem cell yield depends on species-specific circadian timing. Cell Stem Cell 3, 364–366 (2008).

  101. 101.

    Pinho, S. et al. PDGFRalpha and CD51 mark human nestin+sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion. J. Exp. Med. 210, 1351–1367 (2013).

  102. 102.

    Omatsu, Y. et al. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 33, 387–399 (2010).

  103. 103.

    Cordeiro Gomes, A. et al. Hematopoietic stem cell niches produce lineage-instructive signals to control multipotent progenitor differentiation. Immunity 45, 1219–1231 (2016).

  104. 104.

    Omatsu, Y., Seike, M., Sugiyama, T., Kume, T. & Nagasawa, T. Foxc1 is a critical regulator of haematopoietic stem/progenitor cell niche formation. Nature 508, 536–540 (2014).

  105. 105.

    Seike, M., Omatsu, Y., Watanabe, H., Kondoh, G. & Nagasawa, T. Stem cell niche-specific Ebf3 maintains the bone marrow cavity. Genes Dev. 32, 359–372 (2018).

  106. 106.

    Yue, R., Zhou, B. O., Shimada, I. S., Zhao, Z. & Morrison, S. J. Leptin receptor promotes adipogenesis and reduces osteogenesis by regulating mesenchymal stromal cells in adult bone marrow. Cell Stem Cell 18, 782–796 (2016).

  107. 107.

    Zhou, B. O., Yue, R., Murphy, M. M., Peyer, J. G. & Morrison, S. J. Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell 15, 154–168 (2014).

  108. 108.

    Mizoguchi, T. et al. Osterix marks distinct waves of primitive and definitive stromal progenitors during bone marrow development. Dev. Cell 29, 340–349 (2014).

  109. 109.

    Asada, N. et al. Differential cytokine contributions of perivascular haematopoietic stem cell niches. Nat. Cell Biol. 19, 214–223 (2017). This study shows that CXCL12 and SCF produced by different perivascular niches (LEPR + versus NG2 + perivascular cells) make distinct contributions to HSC maintenance and localization.

  110. 110.

    Himburg, H. A. et al. Distinct bone marrow sources of pleiotrophin control hematopoietic stem cell maintenance and regeneration. Cell Stem Cell 23, 370–381 (2018).

  111. 111.

    Isern, J. et al. The neural crest is a source of mesenchymal stem cells with specialized hematopoietic stem cell niche function. eLife 3, e03696 (2014).

  112. 112.

    Xu, C. L. et al. Stem cell factor is selectively secreted by arterial endothelial cells in bone marrow. Nat. Commun. 9, 2449 (2018).

  113. 113.

    Joseph, C. et al. Deciphering hematopoietic stem cells in their niches: a critical appraisal of genetic models, lineage tracing, and imaging strategies. Cell Stem Cell 13, 520–533 (2013).

  114. 114.

    Ono, N. et al. Vasculature-associated cells expressing nestin in developing bones encompass early cells in the osteoblast and endothelial lineage. Dev. Cell 29, 330–339 (2014).

  115. 115.

    Morikawa, S. et al. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J. Exp. Med. 206, 2483–2496 (2009).

  116. 116.

    Breitbach, M. et al. In vivo labeling by CD73 marks multipotent stromal cells and highlights endothelial heterogeneity in the bone marrow niche. Cell Stem Cell 22, 262–276 (2018).

  117. 117.

    Chan, C. K. et al. Identification and specification of the mouse skeletal stem cell. Cell 160, 285–298 (2015).

  118. 118.

    Worthley, D. L. et al. Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential. Cell 160, 269–284 (2015).

  119. 119.

    Short, B. J., Brouard, N. & Simmons, P. J. Prospective isolation of mesenchymal stem cells from mouse compact bone. Methods Mol. Biol. 482, 259–268 (2009).

  120. 120.

    Duchamp de Lageneste, O. et al. Periosteum contains skeletal stem cells with high bone regenerative potential controlled by Periostin. Nat. Commun. 9, 773 (2018).

  121. 121.

    Boulais, P. E. et al. The majority of CD45– Ter119– CD31– bone marrow cell fraction is of hematopoietic origin and contains erythroid and lymphoid progenitors. Immunity 49, 627–639 (2018).

  122. 122.

    Yokota, T. et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96, 1723–1732 (2000).

  123. 123.

    Naveiras, O. et al. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 460, 259–263 (2009). This study suggests that BM adipocytes negatively influence HSC function.

  124. 124.

    Zhu, R. J., Wu, M. Q., Li, Z. J., Zhang, Y. & Liu, K. Y. Hematopoietic recovery following chemotherapy is improved by BADGE-induced inhibition of adipogenesis. Int. J. Hematol. 97, 58–72 (2013).

  125. 125.

    Ambrosi, T. H. et al. Adipocyte accumulation in the bone marrow during obesity and aging impairs stem cell-based hematopoietic and bone regeneration. Cell Stem Cell 20, 771–784 (2017).

  126. 126.

    Zhou, B. O. et al. Bone marrow adipocytes promote the regeneration of stem cells and haematopoiesis by secreting SCF. Nat. Cell Biol. 19, 891–903 (2017).

  127. 127.

    Calvo, W. The innervation of the bone marrow in laboratory animals. Am. J. Anat. 123, 315–328 (1968).

  128. 128.

    Artico, M. et al. Noradrenergic and cholinergic innervation of the bone marrow. Int. J. Mol. Med. 10, 77–80 (2002).

  129. 129.

    Bjurholm, A., Kreicbergs, A., Brodin, E. & Schultzberg, M. Substance P and CGRP-immunoreactive nerves in bone. Peptides 9, 165–171 (1988).

  130. 130.

    Hattori, K. et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97, 3354–3360 (2001).

  131. 131.

    Asada, N. et al. Matrix-embedded osteocytes regulate mobilization of hematopoietic stem/progenitor cells. Cell Stem Cell 12, 737–747 (2013).

  132. 132.

    Semerad, C. L. et al. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 106, 3020–3027 (2005).

  133. 133.

    Christopher, M. J., Rao, M., Liu, F., Woloszynek, J. R. & Link, D. C. Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. J. Exp. Med. 208, 251–260 (2011).

  134. 134.

    Lucas, D. et al. Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration. Nat. Med. 19, 695–703 (2013).

  135. 135.

    Park, M. H. et al. Neuropeptide Y regulates the hematopoietic stem cell microenvironment and prevents nerve injury in the bone marrow. EMBO J. 34, 1648–1660 (2015).

  136. 136.

    Yamazaki, S. et al. Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche. Cell 147, 1146–1158 (2011). This study reports that Schwann cells that ensheath sympathetic nerves along arteries promote HSC quiescence by expressing molecules that activate latent TGFβ.

  137. 137.

    Spiegel, A. et al. Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+cells through Wnt signaling. Nat. Immunol. 8, 1123–1131 (2007).

  138. 138.

    Rameshwar, P. & Gascon, P. Substance P (SP) mediates production of stem cell factor and interleukin-1 in bone marrow stroma: potential autoregulatory role for these cytokines in SP receptor expression and induction. Blood 86, 482–490 (1995).

  139. 139.

    Broome, C. S. & Miyan, J. A. Neuropeptide control of bone marrow neutrophil production. A key axis for neuroimmunomodulation. Ann. NY Acad. Sci. 917, 424–434 (2000).

  140. 140.

    Pierce, H. et al. Cholinergic signals from the CNS regulate G-CSF-mediated HSC mobilization from bone marrow via a glucocorticoid signaling relay. Cell Stem Cell 20, 648–658 (2017).

  141. 141.

    Butler, J. M. et al. Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell 6, 251–264 (2010).

  142. 142.

    Himburg, H. A. et al. Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells. Nat. Med. 16, 475–482 (2010).

  143. 143.

    Winkler, I. G. et al. Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance. Nat. Med. 18, 1651–1657 (2012).

  144. 144.

    Kobayashi, H. et al. Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells. Nat. Cell Biol. 12, 1046–1056 (2010).

  145. 145.

    Poulos, M. G. et al. Endothelial Jagged-1 is necessary for homeostatic and regenerative hematopoiesis. Cell Rep. 4, 1022–1034 (2013).

  146. 146.

    Doan, P. L. et al. Tie2(+) bone marrow endothelial cells regulate hematopoietic stem cell regeneration following radiation injury. Stem Cells 31, 327–337 (2013).

  147. 147.

    Guo, P. et al. Endothelial jagged-2 sustains hematopoietic stem and progenitor reconstitution after myelosuppression. J. Clin. Invest. 127, 4242–4256 (2017).

  148. 148.

    Yao, L., Yokota, T., Xia, L., Kincade, P. W. & McEver, R. P. Bone marrow dysfunction in mice lacking the cytokine receptor gp130 in endothelial cells. Blood 106, 4093–4101 (2005).

  149. 149.

    Nombela-Arrieta, C. & Manz, M. G. Quantification and three-dimensional microanatomical organization of the bone marrow. Blood Adv. 1, 407–416 (2017).

  150. 150.

    Ramalingam, P., Poulos, M. G. & Butler, J. M. Regulation of the hematopoietic stem cell lifecycle by the endothelial niche. Curr. Opin. Hematol. 24, 289–299 (2017).

  151. 151.

    Ito, K. & Ito, K. Hematopoietic stem cell fate through metabolic control. Exp. Hematol. 64, 1–11 (2018).

  152. 152.

    Ramasamy, S. K., Kusumbe, A. P., Wang, L. & Adams, R. H. Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. Nature 507, 376–380 (2014).

  153. 153.

    Grover, A. et al. Single-cell RNA sequencing reveals molecular and functional platelet bias of aged haematopoietic stem cells. Nat. Commun. 7, 11075 (2016).

  154. 154.

    Rodriguez-Fraticelli, A. E. et al. Clonal analysis of lineage fate in native haematopoiesis. Nature 553, 212–216 (2018).

  155. 155.

    Carrelha, J. et al. Hierarchically related lineage-restricted fates of multipotent haematopoietic stem cells. Nature 554, 106–111 (2018).

  156. 156.

    Bruns, I. et al. Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion. Nat. Med. 20, 1315–1320 (2014). This study demonstrates that megakaryocytes directly regulate HSC quiescence by secretion of CXCL4.

  157. 157.

    Zhao, M. et al. Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells. Nat. Med. 20, 1321–1326 (2014). This study demonstrates that megakaryocytes directly regulate HSC quiescence by secretion of TGFβ during homeostasis and regulate HSC recovery after chemotherapy by secretion of FGF1.

  158. 158.

    Nakamura-Ishizu, A., Takubo, K., Fujioka, M. & Suda, T. Megakaryocytes are essential for HSC quiescence through the production of thrombopoietin. Biochem. Biophys. Res. Commun. 454, 353–357 (2014).

  159. 159.

    Nakamura-Ishizu, A., Takubo, K., Kobayashi, H., Suzuki-Inoue, K. & Suda, T. CLEC-2 in megakaryocytes is critical for maintenance of hematopoietic stem cells in the bone marrow. J. Exp. Med. 212, 2133–2146 (2015).

  160. 160.

    Jiang, L. et al. SHP-1 regulates hematopoietic stem cell quiescence by coordinating TGF-beta signaling. J. Exp. Med. 215, 1337–1347 (2018).

  161. 161.

    Dominici, M. et al. Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation. Blood 114, 2333–2343 (2009).

  162. 162.

    Olson, T. S. et al. Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning. Blood 121, 5238–5249 (2013).

  163. 163.

    Herault, A. et al. Myeloid progenitor cluster formation drives emergency and leukaemic myelopoiesis. Nature 544, 53–58 (2017).

  164. 164.

    Winkler, I. G. et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 116, 4815–4828 (2010).

  165. 165.

    Chow, A. et al. Bone marrow CD169+macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J. Exp. Med. 208, 261–271 (2011).

  166. 166.

    Dutta, P. et al. Macrophages retain hematopoietic stem cells in the spleen via VCAM-1. J. Exp. Med. 212, 497–512 (2015).

  167. 167.

    Albiero, M. et al. Bone marrow macrophages contribute to diabetic stem cell mobilopathy by producing oncostatin M. Diabetes 64, 2957–2968 (2015).

  168. 168.

    Ludin, A. et al. Monocytes-macrophages that express alpha-smooth muscle actin preserve primitive hematopoietic cells in the bone marrow. Nat. Immunol. 13, 1072–1082 (2012).

  169. 169.

    Hur, J. et al. CD82/KAI1 maintains the dormancy of long-term hematopoietic stem cells through interaction with DARC-expressing macrophages. Cell Stem Cell 18, 508–521 (2016).

  170. 170.

    Casanova-Acebes, M. et al. Rhythmic modulation of the hematopoietic niche through neutrophil clearance. Cell 153, 1025–1035 (2013).

  171. 171.

    Kawano, Y. et al. G-CSF-induced sympathetic tone provokes fever and primes antimobilizing functions of neutrophils via PGE2. Blood 129, 587–597 (2017).

  172. 172.

    Bowers, E. et al. Granulocyte-derived TNFalpha promotes vascular and hematopoietic regeneration in the bone marrow. Nat. Med. 24, 95–102 (2018).

  173. 173.

    Gandy, K. L., Domen, J., Aguila, H. & Weissman, I. L. CD8+TCR+ and CD8+TCR cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers. Immunity 11, 579–590 (1999).

  174. 174.

    Kaufman, C. L. et al. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 84, 2436–2446 (1994).

  175. 175.

    Fujisaki, J. et al. In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature 474, 216–219 (2011). This study shows that BM T reg cells provide immune privilege for transplanted allogeneic HSCs.

  176. 176.

    Hirata, Y. et al. CD150high bone marrow Tregs maintain hematopoietic stem cell quiescence and immune privilege via adenosine. Cell Stem Cell 22, 445–453 (2018).

  177. 177.

    Geiger, H., de Haan, G. & Florian, M. C. The ageing haematopoietic stem cell compartment. Nat. Rev. Immunol. 13, 376–389 (2013).

  178. 178.

    Morrison, S. J., Wandycz, A. M., Akashi, K., Globerson, A. & Weissman, I. L. The aging of hematopoietic stem cells. Nat. Med. 2, 1011–1016 (1996).

  179. 179.

    de Haan, G., Nijhof, W. & Van Zant, G. Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging ageing: correlation between lifespan and cycling activity. Blood 89, 1543–1550 (1997).

  180. 180.

    Rossi, D. J. et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc. Natl Acad. Sci. USA 102, 9194–9199 (2005).

  181. 181.

    Dykstra, B., Olthof, S., Schreuder, J., Ritsema, M. & de Haan, G. Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells. J. Exp. Med. 208, 2691–2703 (2011).

  182. 182.

    Chen, J., Astle, C. M. & Harrison, D. E. Development and aging of primitive hematopoietic stem cells in BALB/cBy mice. Exp. Hematol. 27, 928–935 (1999).

  183. 183.

    Sudo, K., Ema, H., Morita, Y. & Nakauchi, H. Age-associated characteristics of murine hematopoietic stem cells. J. Exp. Med. 192, 1273–1280 (2000).

  184. 184.

    Cho, R. H., Sieburg, H. B. & Muller-Sieburg, C. E. A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells. Blood 111, 5553–5561 (2008).

  185. 185.

    Beerman, I. et al. Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc. Natl Acad. Sci. USA 107, 5465–5470 (2010).

  186. 186.

    Liang, Y., Van Zant, G. & Szilvassy, S. J. Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells. Blood 106, 1479–1487 (2005).

  187. 187.

    Xing, Z. et al. Increased hematopoietic stem cell mobilization in aged mice. Blood 108, 2190–2197 (2006).

  188. 188.

    Florian, M. C. et al. Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation. Cell Stem Cell 10, 520–530 (2012).

  189. 189.

    Maryanovich, M. et al. Adrenergic nerve degeneration in bone marrow drives aging of the hematopoietic stem cell niche. Nat. Med. 24, 782–791 (2018). This study shows that ageing leads to a loss of innervation of BM arterioles and that aged HSCs can be functionally rejuvenated in vivo by ADRβ3-selective agonist supplementation.

  190. 190.

    Beerman, I. & Rossi, D. J. Epigenetic regulation of hematopoietic stem cell aging. Exp. Cell Res. 329, 192–199 (2014).

  191. 191.

    de Haan, G. & Lazare, S. S. Aging of hematopoietic stem cells. Blood 131, 479–487 (2018).

  192. 192.

    Ergen, A. V., Boles, N. C. & Goodell, M. A. Rantes/Ccl5 influences hematopoietic stem cell subtypes and causes myeloid skewing. Blood 119, 2500–2509 (2012).

  193. 193.

    Yamamoto, R. et al. Large-scale clonal analysis resolves aging of the mouse hematopoietic stem cell compartment. Cell Stem Cell 22, 600–607 (2018).

  194. 194.

    Nakamura-Ishizu, A. & Suda, T. Aging of the hematopoietic stem cells niche. Int. J. Hematol. 100, 317–325 (2014).

  195. 195.

    Guidi, N. et al. Osteopontin attenuates aging-associated phenotypes of hematopoietic stem cells. EMBO J. 36, 1463 (2017).

  196. 196.

    Nishikawa, K. et al. Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation. J. Clin. Invest. 120, 3455–3465 (2010).

  197. 197.

    Singh, L. et al. Aging alters bone-fat reciprocity by shifting in vivo mesenchymal precursor cell fate towards an adipogenic lineage. Bone 85, 29–36 (2016).

  198. 198.

    Adler, B. J., Green, D. E., Pagnotti, G. M., Chan, M. E. & Rubin, C. T. High fat diet rapidly suppresses B lymphopoiesis by disrupting the supportive capacity of the bone marrow niche. PLOS ONE 9, e90639 (2014).

  199. 199.

    Doucette, C. R. et al. A high fat diet increases bone marrow adipose tissue (MAT) but does not alter trabecular or cortical bone mass in C57BL/6J mice. J. Cell. Physiol. 230, 2032–2037 (2015).

  200. 200.

    Poulos, M. G. et al. Endothelial transplantation rejuvenates aged hematopoietic stem cell function. J. Clin. Invest. 127, 4163–4178 (2017).

  201. 201.

    Walkley, C. R. et al. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell 129, 1097–1110 (2007).

  202. 202.

    Walkley, C. R., Shea, J. M., Sims, N. A., Purton, L. E. & Orkin, S. H. Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell 129, 1081–1095 (2007).

  203. 203.

    Kim, Y. W. et al. Defective Notch activation in microenvironment leads to myeloproliferative disease. Blood 112, 4628–4638 (2008).

  204. 204.

    Raaijmakers, M. H. et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 464, 852–857 (2010). This study shows that deletion of the gene encoding the microRNA-processing enzyme Dicer in MSPCs can give rise to myelodysplasia and leukaemia, revealing that primary changes in niche constituents can induce malignant transformation.

  205. 205.

    Zambetti, N. A. et al. Mesenchymal inflammation drives genotoxic stress in hematopoietic stem cells and predicts disease evolution in human pre-leukemia. Cell Stem Cell 19, 613–627 (2016).

  206. 206.

    Dong, L. et al. Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment. Nature 539, 304–308 (2016).

  207. 207.

    Kode, A. et al. Leukaemogenesis induced by an activating beta-catenin mutation in osteoblasts. Nature 506, 240–244 (2014).

  208. 208.

    Krause, D. S. et al. Differential regulation of myeloid leukemias by the bone marrow microenvironment. Nat. Med. 19, 1513–1517 (2013).

  209. 209.

    Wang, L. et al. Notch-dependent repression of miR-155 in the bone marrow niche regulates hematopoiesis in an NF-κB-dependent manner. Cell Stem Cell 15, 51–65 (2014).

  210. 210.

    Wiseman, D. H. Donor cell leukemia: a review. Biol. Blood Marrow Transplant. 17, 771–789 (2011).

  211. 211.

    Boyd, A. L. et al. Niche displacement of human leukemic stem cells uniquely allows their competitive replacement with healthy HSPCs. J. Exp. Med. 211, 1925–1935 (2014).

  212. 212.

    Nervi, B. et al. Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100. Blood 113, 6206–6214 (2009).

  213. 213.

    Zeng, Z. et al. Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML. Blood 113, 6215–6224 (2009).

  214. 214.

    Uy, G. L. et al. A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia. Blood 119, 3917–3924 (2012).

  215. 215.

    Pitt, L. A. et al. CXCL12-producing vascular endothelial niches control acute t cell leukemia maintenance. Cancer Cell 27, 755–768 (2015).

  216. 216.

    Matsunaga, T. et al. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat. Med. 9, 1158–1165 (2003).

  217. 217.

    Jin, L., Hope, K. J., Zhai, Q., Smadja-Joffe, F. & Dick, J. E. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat. Med. 12, 1167–1174 (2006).

  218. 218.

    Krause, D. S., Lazarides, K., von Andrian, U. H. & Van Etten, R. A. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat. Med. 12, 1175–1180 (2006).

  219. 219.

    Schepers, K. et al. Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. Cell Stem Cell 13, 285–299 (2013). This study shows that malignant BCR–ABL CML cells can induce expansion of altered osteolineage progenitors that promote malignancy instead of healthy haematopoiesis.

  220. 220.

    Hanoun, M. et al. Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche. Cell Stem Cell 15, 365–375 (2014). This study shows that AML induces BM neuropathy and altered MSC differentiation with reduced NG2 + niche cells, promoting AML progression instead of healthy haematopoiesis.

  221. 221.

    Duarte, D. et al. Inhibition of endosteal vascular niche remodeling rescues hematopoietic stem cell loss in AML. Cell Stem Cell 22, 64–77 (2018).

  222. 222.

    Frisch, B. J. et al. Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. Blood 119, 540–550 (2012).

  223. 223.

    Hawkins, E. D. et al. T cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments. Nature 538, 518–522 (2016).

  224. 224.

    Wang, W. et al. Aberrant Notch signaling in the bone marrow microenvironment of acute lymphoid leukemia suppresses osteoblast-mediated support of hematopoietic niche function. Cancer Res. 76, 1641–1652 (2016).

  225. 225.

    Battula, V. L. et al. AML-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growth. JCI Insight 2, e90036 (2017).

  226. 226.

    Boyd, A. L. et al. Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow niche. Nat. Cell Biol. 19, 1336–1347 (2017).

  227. 227.

    Hussong, J. W., Rodgers, G. M. & Shami, P. J. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 95, 309–313 (2000).

  228. 228.

    Passaro, D. et al. Increased vascular permeability in the bone marrow microenvironment contributes to disease progression and drug response in acute myeloid leukemia. Cancer Cell 32, 324–341 (2017).

  229. 229.

    Magnon, C. et al. Autonomic nerve development contributes to prostate cancer progression. Science 341, 1236361 (2013).

  230. 230.

    Zahalka, A. H. et al. Adrenergic nerves activate an angio-metabolic switch in prostate cancer. Science 358, 321–326 (2017).

  231. 231.

    Hayakawa, Y. et al. Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling. Cancer Cell 31, 21–34 (2017).

  232. 232.

    Arranz, L. et al. Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms. Nature 512, 78–81 (2014). This study shows that in a mouse model of MPN, BM neuropathy reduces the number of NES + MSCs, which leads, in turn, to an expansion of the population of altered HSPCs and disease progression.

  233. 233.

    Zingariello, M. et al. Characterization of the TGF-β1 signaling abnormalities in the Gata1low mouse model of myelofibrosis. Blood 121, 3345–3363 (2013).

  234. 234.

    Decker, M. et al. Leptin-receptor-expressing bone marrow stromal cells are myofibroblasts in primary myelofibrosis. Nat. Cell Biol. 19, 677–688 (2017).

  235. 235.

    Schneider, R. K. et al. Gli1+ mesenchymal stromal cells are a key driver of bone marrow fibrosis and an important cellular therapeutic target. Cell Stem Cell 20, 785–800 (2017).

  236. 236.

    Croucher, P. I., McDonald, M. M. & Martin, T. J. Bone metastasis: the importance of the neighbourhood. Nat. Rev. Cancer 16, 373–386 (2016).

  237. 237.

    Wang, J. et al. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J. Biol. Chem. 283, 4283–4294 (2008).

  238. 238.

    Shiozawa, Y. et al. Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. J. Clin. Invest. 121, 1298–1312 (2011).

  239. 239.

    Shimoto, M., Sugiyama, T. & Nagasawa, T. Numerous niches for hematopoietic stem cells remain empty during homeostasis. Blood 129, 2124–2131 (2017). This study suggests that the BM may contain many unoccupied niches, as the transplantation of a large number of HSCs engrafted in unconditioned mice, without competing out endogenous HSCs.

  240. 240.

    Silberstein, L. et al. Proximity-based differential single-cell analysis of the niche to identify stem/progenitor cell regulators. Cell Stem Cell 19, 530–543 (2016).

  241. 241.

    Kubota, Y., Takubo, K. & Suda, T. Bone marrow long label-retaining cells reside in the sinusoidal hypoxic niche. Biochem. Biophys. Res. Commun. 366, 335–339 (2008).

  242. 242.

    Takaku, T. et al. Hematopoiesis in 3 dimensions: human and murine bone marrow architecture visualized by confocal microscopy. Blood 116, e41–e55 (2010).

  243. 243.

    Chen, J. Y. et al. Hoxb5 marks long-term haematopoietic stem cells and reveals a homogenous perivascular niche. Nature 530, 223–227 (2016). This study identifies HOXB5 as a new HSC marker that highly enriches for long-term HSCs that associate with SECs using BM chemical clearing and light-sheet microscopy.

  244. 244.

    Richardson, D. S. & Lichtman, J. W. Clarifying tissue clearing. Cell 162, 246–257 (2015).

  245. 245.

    Ito, K. et al. Self-renewal of a purified Tie2 + hematopoietic stem cell population relies on mitochondrial clearance. Science 354, 1156–1160 (2016).

  246. 246.

    Gazit, R. et al. Fgd5 identifies hematopoietic stem cells in the murine bone marrow. J. Exp. Med. 211, 1315–1331 (2014).

  247. 247.

    Koechlein, C. S. et al. High-resolution imaging and computational analysis of haematopoietic cell dynamics in vivo. Nat. Commun. 7, 12169 (2016).

  248. 248.

    Kataoka, K. et al. Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity. J. Exp. Med. 208, 2403–2416 (2011).

  249. 249.

    Sugimura, R. et al. Noncanonical Wnt signaling maintains hematopoietic stem cells in the niche. Cell 150, 351–365 (2012).

  250. 250.

    Cabezas-Wallscheid, N. et al. Vitamin A-retinoic acid signaling regulates hematopoietic stem cell dormancy. Cell 169, 807–823 (2017).

  251. 251.

    Chen, X. et al. Bone marrow myeloid cells regulate myeloid-biased hematopoietic stem cells via a histamine-dependent feedback loop. Cell Stem Cell 21, 747–760 (2017).

  252. 252.

    Tajima, Y. et al. Continuous cell supply from Krt7-expressing hematopoietic stem cells during native hematopoiesis revealed by targeted in vivo gene transfer method. Sci. Rep. 7, 40684 (2017).

  253. 253.

    Hills, D. et al. Hoxb4-YFP reporter mouse model: a novel tool for tracking HSC development and studying the role of Hoxb4 in hematopoiesis. Blood 117, 3521–3528 (2011).

Download references


The authors apologize to investigators whose work could not be cited owing to space limitations. The authors thank the members of the Frenette laboratory for helpful discussions and recognize funding support for their laboratory from the US National Institutes of Health (R01DK056638, R01HL069438, U01DK116312 and R01DK112976), the Leukemia and Lymphoma Society (LLS-TRP 6475-15) and the New York State Department of Health (NYSTEM IIRP C029570 and C029154).

Reviewer information

Nature Reviews Molecular Cell Biology thanks H. Nakauchi and other anonymous reviewers for their contribution to the peer review of this work.

Author information


  1. Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, New York, NY, USA

    • Sandra Pinho
    •  & Paul S. Frenette
  2. Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York, NY, USA

    • Sandra Pinho
    •  & Paul S. Frenette
  3. Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, NY, USA

    • Sandra Pinho
    •  & Paul S. Frenette


  1. Search for Sandra Pinho in:

  2. Search for Paul S. Frenette in:


The authors contributed equally to all aspects of the article.

Competing interests

The authors declare no competing interests.

Corresponding author

Correspondence to Paul S. Frenette.



An in vivo procedure to replace the haematopoietic system of a recipient by delivering a sufficient total number of bone marrow cells from a donor or enriched populations of haematopoietic stem and progenitor cells.


The capacity of a cell to divide and give rise to identical cells with equivalent developmental potential resulting either from an asymmetrical cell division that yields a daughter cell and a cell committed to differentiation or from a symmetrical cell division that yields two identical daughter cells.

Genotoxic insults

Radiation or chemical agents that induce damage to the genetic material in cells.


The capacity of a single cell to give rise to progeny of multiple lineages.


The return of haematopoietic stem cells to the bone marrow by trans-endothelial migration.


The process by which, following homing, haematopoietic stem cells anchor in a specific region.


Tissue that covers the outer surface of the bone and consists of two layers: an outer fibrous layer that contains fibroblasts and collagen fibres and an inner cambium layer that consists of osteoblasts and skeletal stem cells with bone regeneration capacity.


Specialized thin-walled capillaries with a wide lumen. Sinusoids distribute evenly throughout the bone marrow and form a web of fenestrated vessels that facilitate trafficking of haematopoietic cells and factors in and out of the circulation.

Cortical bone

A type of bone tissue, also known as compact bone, that has a mechanical function, forming a hard shell for long-bone diaphysis and accounting for the majority of total bone mass in the human skeleton.


Inner surface of bone cavities and the outer surface of trabeculae bone spicules within the cavities covered by bone-forming osteoblasts and bone-resorbing osteoclasts.

Trabecular bone

A type of bone tissue, also known as cancellous or spongy bone, that actively remodels and is mostly present in flat and irregular bones as well as in the epiphysis and metaphysis of long bones.

Bone marrow stromal cells

Cells of non-haematopoietic origin (classically defined as CD45TER119) in the bone marrow. Stromal cells may or may not include endothelial cells, depending on whether cells that express CD31 or tyrosine kinase with immunoglobulin and EGF homology domains 2 (TIE2) are included in the definition.

Mesenchymal stem cells

(MSCs). Self-renewing precursor cells that can differentiate into bone, fat or cartilage and form stromal cells of the bone marrow.


The state of being inactive or dormant in the G0 phase of the cell cycle, which is important for long-term function.

Mesenchymal stem and progenitor cells

(MSPCs). A population of stromal cells that remains undefined but is expected to contain self-renewing mesenchymal stem cells and colony-forming mesenchymal progenitor cells.

Sympathetic nervous system

(SNS). A branch of the autonomic nervous system that emerges from the thoracolumbar spinal cord and prepares the body for situations requiring alertness by releasing noradrenaline, which binds to adrenergic receptors.

Perivascular niches

Specialized microenvironments located adjacent to the bone marrow vasculature that regulate the maintenance of haematopoietic stem cells and/or progenitor cells.


The process by which donor haematopoietic stem cells persist in the host, generate mature progeny and repopulate the haematopoietic stem cell pool.


A state in which the numbers and/or function of HSPCs are compromised owing to high turnover as a consequence of high demand for reconstitution in stress or serial transplantation.


In the context of transplantation, cells or tissue that are from the same species but are genetically different from the recipient.

About this article

Publication history